Anti-inflammatory medication in cataract surgery of pseudoexfoliation eyes

Phase 1

• Conditions: Cataract senilis; Therapeutic area: Diseases [C] - Eye Diseases [C11]

• Registration Number: EUCTR2016-004784-40-FI
• Lead Sponsor: Raimo Tuuminen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-30
• Last Update Posted: 3 April 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Pseudoexfoliation
Age 60-90 years
Fullfills national criteria for cataract surgery

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 120

Exclusion Criteria

Diabetes.
Active wet AMD /planned anti-VEGF therapy
prior retinal vein/artery occlusion, retinal detachment, optic neuritis,
vitreous hemorrhage, intraocular surgery.
Myopia magna.
Pregnancy.
Alcohol misuse.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified